J 2014

Tobacco Dependence, the Most Important Cardiovascular Risk Factor: Treatment in the Czech Republic

KRÁLÍKOVÁ, E.; A. KMEŤOVÁ; L. ŠTĚPÁNKOVÁ; K. ZVOLSKÁ; V. FELBROVÁ et al.

Základní údaje

Originální název

Tobacco Dependence, the Most Important Cardiovascular Risk Factor: Treatment in the Czech Republic

Autoři

KRÁLÍKOVÁ, E.; A. KMEŤOVÁ; L. ŠTĚPÁNKOVÁ; K. ZVOLSKÁ; V. FELBROVÁ; S. KULOVANÁ; Zbyněk BORTLÍČEK; Milan BLAHA a K. FRASER

Vydání

Physiological Research, Prague, Institute of Physiology, Academy of Sciences of the Czech Republic, 2014, 0862-8408

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30105 Physiology

Stát vydavatele

Česká republika

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 1.293

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/14:00078320

Organizační jednotka

Lékařská fakulta

Klíčová slova anglicky

Tobacco dependence; Smoking cessation; Cardiovascular risk

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 14. 1. 2015 14:42, Soňa Böhmová

Anotace

V originále

Smoking is the most important cardiovascular (CV) risk factor. Stopping smoking halves the CV risk. Every clinician should provide a brief intervention with smokers. Intensive treatment should be available to those who need it. There are 37 Centers for Tobacco Dependence in the Czech Republic, which offer treatment including a psychobehavioral intervention and pharmacotherapy (varenicline, nicotine, bupropion). Czech physicians, pharmacists and nurses are regularly educated about smoking cessation. We describe the results of intensive treatment offered by our centers. Treatment includes screening (1 h), an intervention (2 h), and follow-up visits during the next 12 months. Among 3532 patients, 34.3 % had CO-validated abstinence at 12-months (including 489 patients who attended the screening visit + only the 12-month follow up visit). Among patients who underwent the intervention, the abstinence rate was 38.2 %. The majority of patients who underwent the intervention (N = 2470) used some form of pharmacotherapy. After one year, the abstinence rate was 43.4 %, compared to 15.9 % (N= 573) without pharmacotherapy. Only 28 % of patients came on the recommendation of a physician. Despite the decrease in CV risk following smoking cessation and the effectiveness of treatment, centers are underutilized.